IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Becker, S. I.
Right arrow Articles by Gardner, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Becker, S. I.
Right arrow Articles by Gardner, M. J.

 Previous Article  |  Next Article 

Infect Immun, July 1998, p. 3457-3461, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Protection of Mice against Plasmodium yoelii Sporozoite Challenge with P. yoelii Merozoite Surface Protein 1 DNA Vaccines

Sylvia I. Becker,1,dagger Ruobing Wang,1 Richard C. Hedstrom,1 Joao C. Aguiar,1,2 Trevor R. Jones,1 Stephen L. Hoffman,1,* and Malcolm J. Gardner1,3,Dagger

Malaria Program, Naval Medical Research Institute, Bethesda, Maryland 20889-56071; Pan American Health Organization, Washington, D.C. 200372; and Department of Microbiology and Immunology, University of Maryland at Baltimore, Baltimore, Maryland 21201-15593

Received 13 November 1997/Returned for modification 22 January 1998/Accepted 10 April 1998

Immunization of mice with DNA vaccines encoding the full-length form and C and N termini of Plasmodium yoelii merozoite surface protein 1 provided partial protection against sporozoite challenge and resulted in boosting of antibody titers after challenge. In C57BL/6 mice, two DNA vaccines provided protection comparable to that of recombinant protein consisting of the C terminus in Freund's adjuvant.

* Corresponding author. Mailing address: Malaria Program, Naval Medical Research Institute, 12300 Washington Ave., Rockville, MD 20852. Phone: (301) 295-0026. Fax: (301) 295-6171. E-mail: hoffmans{at}nmripo.nmri.nnmc.navy.mil.

dagger Present address: 2356 E. Seneca St., Tucson, AZ 85719.

Dagger Present address: The Institute for Genomic Research, Rockville, MD 20850.

Infect Immun, July 1998, p. 3457-3461, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 1998 by the American Society for Microbiology. All rights reserved.